A pediatrician's cough conundrum

Early this month, just before a hearing by the Food and Drug Administration, drug companies decided to pull from the market 14 multisymptom cold and cough medicines aimed at infants and toddlers. A week later, an FDA advisory panel recommended banning these medications for all children under 6. (Full article: 817 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $4.95 1 article
• $9.95 4 articles
• $25.95 Monthly